Africa and LATAM Enteral Nutrition Market to Reach $465.32 Million by 2034, at CAGR of 5.8% from 2024 to 2034.

According to a new report published by Allied Market Research, titled, " Africa and LATAM Enteral Nutrition Market by Product Composition (Standard Enteral Nutrition, Disease Specific and Others), Age Group (Infant (0-12 Months), Pediatric (1-18 Years), Adult (18-64 Years), and Geriatric (65 Years and above)), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others): Opportunity Analysis and Industry Forecast, 2024–2034"

The Africa and LATAM Enteral Nutrition Market was valued at $252.66 million in 2023 and is estimated to reach $465.32 million by 2034, exhibiting a CAGR of 5.8% from 2024 to 2034. Enteral nutrition is a method of delivering nutrients directly into the gastrointestinal (GI) tract, typically through a tube, when a patient is unable to consume food orally but still has a functioning digestive system. It is commonly used for individuals with conditions such as neurological disorders, head or neck cancers, severe swallowing difficulties (dysphagia), or critical illness requiring nutritional support.

Enteral feeding can be administered via various routes, including nasogastric (NG), nasojejunal (NJ), gastrostomy (G-tube), or jejunostomy (J-tube), depending on the patient’s needs and duration of therapy. Nutritional formulas used in enteral feeding are specially designed to meet the individual's caloric, protein, vitamin, and mineral requirements, and may be tailored for specific conditions such as diabetes, kidney disease, or malabsorption syndromes. Compared to parenteral nutrition (which bypasses the GI tract), enteral nutrition is generally preferred due to its lower risk of infection, maintenance of gut integrity, and cost-effectiveness.

Major factors driving the growth of the Africa and LATAM Enteral Nutrition Market include growing aging population, increasing incidence of malnutrition and improving healthcare infrastructure. The United Nations Department of Economic and Social Affairs estimates that Africa's population aged 60 and above is expected to rise from 74.4 million in 2020 to approximately 225 million by 2050, an almost 200% increase in just three decades. As the continent experiences a demographic shift with a rising proportion of elderly individuals, the prevalence of agerelated health conditions such as chronic diseases, malnutrition, and impaired swallowing increases significantly. Older adults often face difficulties in consuming food orally due to conditions like stroke, dementia, or post-surgical recovery, which heightens the demand for enteral nutrition as a reliable and effective method of delivering essential nutrients directly to the gastrointestinal tract. In addition, healthcare providers increasingly recognize the benefits of enteral nutrition in improving patient outcomes and reducing hospital stays among geriatric patients. Thus, the rise in geriatric population is expected to drive the Africa and LATAM Enteral Nutrition Market growth.

The increasing incidence of malnutrition across Africa is a major factor driving the growth of the enteral nutrition market in the region. According to World Hungry Education Services, around 57 million people in Africa (29.1 % of the population) were chronically undernourished in 2022. Widespread poverty, food insecurity, and limited access to quality healthcare contribute to chronic undernutrition, particularly among vulnerable populations such as children, the elderly, and patients with chronic illnesses. This has led to a growing demand for therapeutic nutritional support, with enteral nutrition emerging as a vital solution for managing both acute and chronic cases of malnutrition. In addition, the rising prevalence of diseases such as cancer, gastrointestinal disorders, and neurological conditions, which often impair the ability to consume or absorb nutrients orally, has further necessitated the use of enteral feeding.

The Africa and LATAM Enteral Nutrition Market is segmented on the basis of age group, product composition, distribution channel, and region. On the basis of age group, the market is divided into adult, geriatric, infant, and paediatric. On the basis of product composition, the market is divided into standard enteral nutrition, disease specific, and others.

On the basis of distribution channel, the Africa and LATAM Enteral Nutrition market is divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. Region-wise, the Africa and LATAM Enteral Nutrition market is analysed across North Africa (Egypt, Algeria, Morocco, Libya, and Rest of North Africa), West Africa (Nigeria, Ghana, and rest of West Africa), East Africa (Kenya, Ethiopia, Uganda, Tanzania, Madagascar, Mauritius, and rest of East Africa), South Africa (South Africa, Zambia, Zimbabwe, and Rest Of South Africa), French West Africa (Ivory, Senegal, Mali, Burkina Faso, Cameroon, and Rest Of French West Africa), and LATAM (Brazil, Mexico, Dominican Republic, Chile, Colombia, Peru, Bolivia, and Rest Of LATA).

On the basis of age group, the adult segment was the major revenue contributor in 2023, owing to the rising prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders among the adult population. However, the paediatric segment is expected to register the highest CAGR during the forecast period, owing to rising incidence of paediatric malnutrition, particularly in low-income and rural regions. Many countries in Africa continue to face challenges related to food insecurity, poor maternal health, and inadequate access to essential healthcare services, all of which contribute to high rates of undernutrition among children.

On the basis of product composition, the standard enteral nutrition segment was the major revenue contributor in 2023. This is attributed to the rise in incidence of pediatric malnutrition, particularly in low-income and rural areas. Many countries in Africa continue to face challenges related to food insecurity, poor maternal health, and inadequate access to essential healthcare services, all of which contribute to high rates of undernutrition among children.

However, the disease specific segment is expected to register the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and lifestyle-related diseases that require specialized nutritional support. Conditions such as diabetes, cancer, renal disorders, and gastrointestinal diseases are becoming more common across the continent, driven by changing lifestyles, urbanization, and aging populations.

On the basis of distribution channel, the Hospital Pharmacies segment was the major revenue contributor in 2023. This is attributed to the rising number of hospital admissions related to chronic illnesses, malnutrition, and critical care needs, where enteral nutrition plays a vital role in patient recovery and management.

Hospitals serve as primary centres for treating severe conditions such as cancer, gastrointestinal disorders, and neurological impairments, which often require medically supervised nutritional support. However, the Online Pharmacies segment is expected to register the highest CAGR during the forecast period, owing to the increasing penetration of internet services, the widespread use of smartphones, and the growing acceptance of digital health platforms across the continent.

On the basis of region, LATAM accounted for a majority of the Africa and LATAM Enteral Nutrition Market share in 2023. This is attributed to its relatively advanced healthcare infrastructure, growing awareness about clinical nutrition, and higher healthcare spending compared to other countries in the region. The presence of well-established hospitals and healthcare facilities that actively incorporate enteral nutrition in the management of chronic diseases, such as cancer, gastrointestinal disorders, and neurological conditions, has significantly contributed to Africa and LATAM Enteral Nutrition market growth. However, French West Africa is anticipated to witness the fastest growth during the forecast period, owing to due to rapid improvements in healthcare infrastructure, increasing investments in medical services, and growing awareness about the benefits of clinical nutrition

Key Findings of the Study

• By age group, the adult segment was the highest contributor to the Africa and LATAM Enteral Nutrition market in 2023. However, the paediatric segment is expected to register the highest CAGR in the forecast period.
• By product composition, the standard enteral nutrition segment was the highest contributor to the Africa and LATAM Enteral Nutrition market in 2023. However, the disease-specific segment is expected to register the highest CAGR in the forecast period.
• By distribution channel, the hospital pharmacies segment was the highest contributor to the Africa and LATAM Enteral Nutrition market in 2023. However, the online pharmacies segment is expected to register the highest CAGR in the forecast period.
• By region, LATAM garnered the largest revenue share in 2023. However, French West Africa is expected to grow at the fastest rate during the forecast period.